Nuvalent Corporate Overview 2022

Nuvalent is a clinical-stage biopharmaceutical company developing targeted cancer therapies using structure-based drug design. The company's pipeline includes NVL-520, NVL-655, and NVL-330, with ongoing ARROS-1 and ALKOVE-1 clinical studies for ALK-driven tumors.